Risk Evaluation and Mitigation Strategies
id:
risk-evaluation-and-mitigation-strategies-247-3333634
title:
Risk Evaluation and Mitigation Strategies
text:
Risk Evaluation and Mitigation Strategies (REMS) is a program of the US Food and Drug Administration for the monitoring of medications with a high potential for serious adverse effects. REMS applies only to specific prescription drugs, but can apply to brand name or generic drugs. The REMS program was formalized in 2007. The FDA determines as part of the drug approvals process that a REMS is necessary, and the drug company develops and maintains the individual program. REMS applies only to speci
brand slug:
wiki
category slug:
encyclopedia
description:
original url:
https://en.wikipedia.org/wiki/Risk_Evaluation_and_Mitigation_Strategies
date created:
date modified:
2023-03-16T08:11:05Z
main entity:
{"identifier":"Q55631740","url":"https://www.wikidata.org/entity/Q55631740"}
image:
fields total:
13
integrity:
13